Given that IL-6 not only impacts on metabolism but also on the development of cancer and that obesity increases the incidence of cancer entities with an inflammatory microenvironment, the context-specific dissection of signaling cascades will be necessary for the development of novel therapeutic interventions to combat such fatal obesity-associated diseases [68]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.